ROIV
Roivant Sciences Ltd.
Stock
$35.72+0.22 (+0.62%)Close Oct 2, 2026
- Research and development, FY2025
- $682M
- YoY, FY2025
- +23.9%
- 5-year CAGR
- +23.6%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| FY2025 | $682M | +23.9% |
| FY2024 | $550M | +25.1% |
| FY2023 | $440M | −3.1% |
| FY2022 | $454M | −6.0% |
| FY2021 | $483M | +104.1% |
| FY2020 | $237M | — |